Human study of iPS cells advances toward approval in Japan

A panel of Japan's Health Ministry has approved a clinical study involving induced pluripotent stem cells. The study is a type of pretrial clinical research that will focus on the use of iPS cells in treating eye disease. The decision could pave the way for final approval by the health minister.

View Full Article in:

Japan Times, The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX